BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18637124)

  • 41. Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate.
    Delgado J; Pratt G; Phillips N; Briones J; Fegan C; Nomdedeu J; Pepper C; Aventin A; Ayats R; Brunet S; Martino R; Valcarcel D; Milligan D; Sierra J
    Br J Haematol; 2009 Jun; 145(6):801-5. PubMed ID: 19388937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is perceived social support a predictor of survival for patients undergoing autologous peripheral blood stem cell transplantation?
    Frick E; Motzke C; Fischer N; Busch R; Bumeder I
    Psychooncology; 2005 Sep; 14(9):759-70. PubMed ID: 15744779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Review of 1027 patients with newly diagnosed multiple myeloma.
    Kyle RA; Gertz MA; Witzig TE; Lust JA; Lacy MQ; Dispenzieri A; Fonseca R; Rajkumar SV; Offord JR; Larson DR; Plevak ME; Therneau TM; Greipp PR
    Mayo Clin Proc; 2003 Jan; 78(1):21-33. PubMed ID: 12528874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fatigue dimensions in patients with advanced cancer in relation to time of survival and quality of life.
    Hagelin CL; Wengström Y; Ahsberg E; Fürst CJ
    Palliat Med; 2009 Mar; 23(2):171-8. PubMed ID: 18952749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality of life of the community-based patients with mild cognitive impairment.
    Muangpaisan W; Assantachai P; Intalapaporn S; Pisansalakij D
    Geriatr Gerontol Int; 2008 Jun; 8(2):80-5. PubMed ID: 18713159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patient satisfaction with quality of life as a prognostic indicator in ovarian cancer patients treated in an integrative treatment setting.
    Gupta D; Grutsch JF; Lis CG
    J Soc Integr Oncol; 2008; 6(3):98-104. PubMed ID: 19087766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Soluble syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survival.
    Lovell R; Dunn JA; Begum G; Barth NJ; Plant T; Moss PA; Drayson MT; Pratt G;
    Br J Haematol; 2005 Aug; 130(4):542-8. PubMed ID: 16098068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prognositic factors in multiple myeloma].
    Nagura E
    Nihon Rinsho; 2007 Dec; 65(12):2351-6. PubMed ID: 18069282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bortezomib is associated with better health-related quality of life than high-dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX study.
    Lee SJ; Richardson PG; Sonneveld P; Schuster MW; Irwin D; San Miguel JF; Crawford B; Massaro J; Dhawan R; Gupta S; Anderson KC
    Br J Haematol; 2008 Nov; 143(4):511-9. PubMed ID: 18986387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quality of life impact as outcome in burns patients.
    Novelli B; Melandri D; Bertolotti G; Vidotto G
    G Ital Med Lav Ergon; 2009; 31(1 Suppl A):A58-63. PubMed ID: 19621540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic factors in the diagnostic work-up of cancer patients in an internal medicine department: does age matter?
    Domingo E; Suriñach JM; Murillo J; Duran M; Suriñach J; Baselga J; de Sevilla TF
    Int J Clin Pract; 2008 Nov; 62(11):1723-9. PubMed ID: 19143858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polyclonal immunoglobulin E levels are correlated with hemoglobin values and overall survival in patients with multiple myeloma.
    Matta GM; Battaglio S; Dibello C; Napoli P; Baldi C; Ciccone G; Coscia M; Boccadoro M; Massaia M
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5348-54. PubMed ID: 17875762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.
    Harousseau JL; Avet-Loiseau H; Attal M; Charbonnel C; Garban F; Hulin C; Michallet M; Facon T; Garderet L; Marit G; Ketterer N; Lamy T; Voillat L; Guilhot F; Doyen C; Mathiot C; Moreau P
    J Clin Oncol; 2009 Dec; 27(34):5720-6. PubMed ID: 19826130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic factors affecting the survival of patients with multiple myeloma. A retrospective analysis of 86 patients.
    Rapoport BL; Falkson HC; Falkson G
    S Afr Med J; 1991 Jan; 79(2):65-7. PubMed ID: 1989088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Serum LDH and myeloma. Correlation with the degree of bone marrow infiltration].
    Ogea García JL; Blanco Molina MA; Andrés P; Muñoz R; Jiménez Alonso J; Pérez Jiménez F
    Rev Esp Oncol; 1985; 32(2):207-13. PubMed ID: 3843455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma.
    Witzig TE; Gertz MA; Lust JA; Kyle RA; O'Fallon WM; Greipp PR
    Blood; 1996 Sep; 88(5):1780-7. PubMed ID: 8781435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation.
    Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I
    Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.